Hankins W D, Krantz S B
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5287-91. doi: 10.1073/pnas.77.9.5287.
The Friend polycythemia virus complex (FVP), consisting of the replication-defective spleen focus-forming virus (SFFV) and a helper Friend murine leukemia virus (MuLV-F), produces erythroleukemia within 2-3 weeks in vivo. We have recently reported in vitro transformation of bone marrow cells by FVP, producing clusters of erythroid colonies (erythroid bursts) 4-6 days after infection. In contrast to uninfected bone marrow cells, FVP-treated cells proliferated and differentiated (synthesized hemoglobin) in the absence of added erythropoietin, the physiologic regulator of erythropoiesis. The relative roles of helper murine leukemia virus (MuLV) and SFFV in the in vitro erythroid transformation have now been examined. Pseudotype studies and the finding that cloned MuLV-F (free of SFFV) did not induce burst formation indicated that SFFV was essential for this in vitro effect of FVP. Because SFFV could not be obtained free of helper MuLV, we assessed the requirement of MuLV in the transformation by kinetic analyses of helper-deficient and helper-excess FVP preparations. Whereas helper-excess FVP gave single-hit kinetics both in vivo and in vitro, the helper-deficient FVP followed multiple-hit kinetics when titrated for spleen focus formation in vivo. Addition of MuLV-F to helper-deficient FVP prior to injection resulted in a marked enhancement of spleen focus formation and a conversion from multiple-hit to single-hit kinetics. In contrast, titration of this same preparation for erythroid burst transformation in vitro yielded single-hit kinetics, and the addition of helper MuLV-F had no effect. The time course of burst development was similar with or without added MuLV-F. Unlike burst transformation, SFFV production by these infected cultures followed multiple-hit kinetics. Addition of MuLV-F at the time of infection led to an enhancement of SFFV production and conversion of the titration curve from multiple-hit to single-hit. These data are consistent with the idea that SFFV is competent for erythroid transformation in vitro, but requires helper MuLV for its replication.
Friend红细胞增多症病毒复合体(FVP)由复制缺陷型脾集落形成病毒(SFFV)和辅助性Friend小鼠白血病病毒(MuLV-F)组成,可在体内2至3周内引发红细胞白血病。我们最近报道了FVP对骨髓细胞的体外转化,感染后4至6天可产生红细胞集落簇(红细胞爆发)。与未感染的骨髓细胞相比,经FVP处理的细胞在未添加促红细胞生成素(红细胞生成的生理调节因子)的情况下仍能增殖和分化(合成血红蛋白)。现在已经研究了辅助性小鼠白血病病毒(MuLV)和SFFV在体外红细胞转化中的相对作用。假型研究以及克隆的MuLV-F(不含SFFV)未诱导爆发形成的发现表明,SFFV对于FVP的这种体外效应至关重要。由于无法获得不含辅助性MuLV的SFFV,我们通过对辅助缺陷型和辅助过量型FVP制剂的动力学分析来评估MuLV在转化中的需求。辅助过量的FVP在体内和体外均呈现单 hit 动力学,而辅助缺陷型FVP在体内进行脾集落形成滴定测定时遵循多 hit 动力学。在注射前向辅助缺陷型FVP中添加MuLV-F可显著增强脾集落形成,并从多 hit 动力学转变为单 hit 动力学。相比之下,对同一制剂进行体外红细胞爆发转化滴定测定时呈现单 hit 动力学,添加辅助性MuLV-F没有影响。无论是否添加MuLV-F,爆发发展的时间进程相似。与爆发转化不同,这些感染培养物中SFFV的产生遵循多 hit 动力学。在感染时添加MuLV-F可导致SFFV产生增加,滴定曲线从多 hit 转变为单 hit。这些数据与以下观点一致,即SFFV在体外能够进行红细胞转化,但需要辅助性MuLV进行复制。